News
Canada Approves Ozempic to Reduce Risk of Diabetic Kidney Disease Progression
(Reuters) -Canada's health regulator has approved Novo Nordisk's diabetes drug, Ozempic, for reducing the risk of kidney failure and disease progression, as well as death due to heart problems in diabetes patients with chronic kidney disease, the Danish drugmaker said on Tuesday.
Copycat versions of popular drugs like Ozempic and Mounjaro have continued to proliferate in a postshortage era, with some experts saying "regulatory neglect" is allowing for potentially dangerous, ...
It’s not just above the waistline where the effects of Ozempic are taking place. Hush-hush conversations online have revealed ...
The Little Mix singer said she auditioned for "The X Factor" just months after leaving the hospital, where she was treated ...
A woman who said she got 'Ozempic vulva' explained what getting the side effect of rapid weight loss was really like. The number of people taking drugs for weight loss has absolutely boomed in recent ...
Ozempic, the viral weight-loss injection, is now in the dock with $2 billion lawsuits as patients allege stomach paralysis, ...
In the UK, patients can buy a four-week supply of Ozempic for between £119 and £190 from online pharmacies. Novo Nordisk said ...
GLP-1s, injectable drugs that mimic hormones to reduce blood sugar and promote weight loss, have skyrocketed in popularity.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback